Morgan Stoneman
Family · Carson City, MINPI 1518542844
Payments from drug & device makers
Across 210 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$491
- Boehringer Ingelheim$405
- Mylan Specialty L.p.$307
- Actelion Pharmaceuticals US, Inc.$188
- Novo Nordisk$154
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,02098%
- Education$772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 41 | $1,031 |
| GSK | 37 | $491 |
| Boehringer Ingelheim | 25 | $405 |
| Mylan Specialty L.p. | 16 | $307 |
| Actelion Pharmaceuticals US, Inc. | 7 | $188 |
| Novo Nordisk | 8 | $154 |
| Amgen | 8 | $150 |
| Philips North America LLC | 7 | $150 |
| Harmony Biosciences LLC | 5 | $130 |
| Regeneron Healthcare Solutions, Inc. | 4 | $104 |
| AbbVie | 6 | $103 |
| Mallinckrodt Hospital Products Inc. | 4 | $93 |
| Lilly USA, LLC | 4 | $71 |
| Teva Pharmaceuticals USA, Inc. | 4 | $63 |
| Electromed, Inc. | 4 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Covis Pharma GmbH | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Grifols USA, LLC | 2 | $46 |
| Organon | 2 | $44 |
| Resmed Corp | 2 | $39 |
| Neurelis, Inc. | 2 | $39 |
| Exact Sciences | 2 | $34 |
| Sanofi | 1 | $28 |
| Penumbra, Inc. | 2 | $27 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| Johnson & Johnson | 1 | $23 |
| United Therapeutics Corporation | 1 | $23 |
| Verona Pharma, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Bayer | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
| Insmed, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,097 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 215 | $291,464 |
| Spiriva RespimatTiotropium Bromide | 39 | $41,290 |
| TrulicityDulaglutide | 36 | $37,745 |
| EliquisApixaban | 33 | $35,979 |
| MounjaroTirzepatide | 21 | $22,430 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $20,491 |
| OzempicSemaglutide | 17 | $15,777 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $11,830 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 181 | $7,093 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,838 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $3,723 |
| Montelukast Sodium | 152 | $2,669 |
| Ventolin HfaAlbuterol Sulfate | 21 | $1,946 |
| Atorvastatin Calcium | 117 | $1,535 |
| Pregabalin | 17 | $1,524 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $491 | $303,294234 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $71 | $60,17657 claims |
| Boehringer IngelheimSpiriva Respimat | $405 | $41,29039 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,031 | $24,32928 claims |
| Novo NordiskOzempic | $154 | $15,77717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,657 family providers in Michigan.
Other family in Carson City
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.